The conclusion of the research was that squalene epoxidase inhibitors are novel tumor-specific radiosensitizers that promote ER stress and suppress homologous recombination, providing a novel potential therapeutic approach to improve radiotherapy efficacy. This evidence concerns the gene SQLE and neoplasm.